{"id":"https://openalex.org/W891726648","doi":null,"title":"Potencjalna rola wielonienasyconych kwas\u00f3w t\u0142uszczowych omega-3 w terapii schizofrenii oraz profilaktyce wt\u00f3rnej w\u015br\u00f3d os\u00f3b zagro\u017conych rozwojem psychozy: dane z randomizowanych, kontrolowanych placebo bada\u0144 klinicznych oraz metaanaliz","display_name":"Potencjalna rola wielonienasyconych kwas\u00f3w t\u0142uszczowych omega-3 w terapii schizofrenii oraz profilaktyce wt\u00f3rnej w\u015br\u00f3d os\u00f3b zagro\u017conych rozwojem psychozy: dane z randomizowanych, kontrolowanych placebo bada\u0144 klinicznych oraz metaanaliz","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W891726648","mag":"891726648"},"language":"pl","primary_location":{"id":"mag:891726648","doi":null,"is_oa":true,"landing_page_url":"http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.psjd-5a24a6af-8ef5-4854-97a6-c256a03649e9/c/potencjalna-rola-wielonienasyconych-kwasow-tluszczowych-omega-3-w-terapii-schizofrenii-oraz-profilaktyce-wtornej-wsrod-osob-zagrozonych-rozwojem-psychozy-dane-z-randomizowanych-kontrolowanych-placebo-badan-klinicznych-ora.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2739126905","display_name":"Psychiatria i Psychologia Kliniczna","issn_l":"1644-6313","issn":["1644-6313","2451-0645"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310317365","host_organization_name":"Medical Communications Sp. z o.o.","host_organization_lineage":["https://openalex.org/P4310317365"],"host_organization_lineage_names":["Medical Communications Sp. z o.o."],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Psychiatria i Psychologia Kliniczna","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.psjd-5a24a6af-8ef5-4854-97a6-c256a03649e9/c/potencjalna-rola-wielonienasyconych-kwasow-tluszczowych-omega-3-w-terapii-schizofrenii-oraz-profilaktyce-wtornej-wsrod-osob-zagrozonych-rozwojem-psychozy-dane-z-randomizowanych-kontrolowanych-placebo-badan-klinicznych-ora.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038875827","display_name":"Tomasz Pawe\u0142czyk","orcid":"https://orcid.org/0000-0002-1421-2050","observed_orcids":["https://orcid.org/0000-0002-1421-2050"]},"institutions":[{"id":"https://openalex.org/I4210122071","display_name":"Medical University of Lodz","ror":"https://ror.org/02t4ekc95","country_code":"PL","type":"education","lineage":["https://openalex.org/I4210122071"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Tomasz Pawe\u0142czyk","raw_affiliation_strings":["Klinika Zaburze\u0144 Afektywnych i Psychotycznych Katedry Psychiatrii Uniwersytetu Medycznego w \u0141odzi. Kierownik: prof. dr hab. n. med. Jolanta Rabe-Jab\u0142o\u0144ska"],"raw_orcid":"https://orcid.org/0000-0002-1421-2050","affiliations":[{"raw_affiliation_string":"Klinika Zaburze\u0144 Afektywnych i Psychotycznych Katedry Psychiatrii Uniwersytetu Medycznego w \u0141odzi. Kierownik: prof. dr hab. n. med. Jolanta Rabe-Jab\u0142o\u0144ska","institution_ids":["https://openalex.org/I4210122071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051622348","display_name":"Agnieszka Maria Pawe\u0142czyk","orcid":"https://orcid.org/0000-0003-1900-0214","observed_orcids":["https://orcid.org/0000-0003-1900-0214"]},"institutions":[{"id":"https://openalex.org/I4210122071","display_name":"Medical University of Lodz","ror":"https://ror.org/02t4ekc95","country_code":"PL","type":"education","lineage":["https://openalex.org/I4210122071"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Agnieszka Pawe\u0142czyk","raw_affiliation_strings":["Klinika Zaburze\u0144 Afektywnych i Psychotycznych Katedry Psychiatrii Uniwersytetu Medycznego w \u0141odzi. Kierownik: prof. dr hab. n. med. Jolanta Rabe-Jab\u0142o\u0144ska"],"raw_orcid":"https://orcid.org/0000-0003-1900-0214","affiliations":[{"raw_affiliation_string":"Klinika Zaburze\u0144 Afektywnych i Psychotycznych Katedry Psychiatrii Uniwersytetu Medycznego w \u0141odzi. Kierownik: prof. dr hab. n. med. Jolanta Rabe-Jab\u0142o\u0144ska","institution_ids":["https://openalex.org/I4210122071"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041434525","display_name":"Jolanta Rabe\u2010Jab\u0142o\u0144ska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122071","display_name":"Medical University of Lodz","ror":"https://ror.org/02t4ekc95","country_code":"PL","type":"education","lineage":["https://openalex.org/I4210122071"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Jolanta Rabe\u2010Jab\u0142o\u0144ska","raw_affiliation_strings":["Klinika Zaburze\u0144 Afektywnych i Psychotycznych Katedry Psychiatrii Uniwersytetu Medycznego w \u0141odzi. Kierownik: prof. dr hab. n. med. Jolanta Rabe-Jab\u0142o\u0144ska"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Klinika Zaburze\u0144 Afektywnych i Psychotycznych Katedry Psychiatrii Uniwersytetu Medycznego w \u0141odzi. Kierownik: prof. dr hab. n. med. Jolanta Rabe-Jab\u0142o\u0144ska","institution_ids":["https://openalex.org/I4210122071"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210122071"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"9","issue":"4","first_page":"270","last_page":"277"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.01600000075995922,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/omega-3-fatty-acids","display_name":"omega-3 fatty acids","score":0.8669999837875366},{"id":"https://openalex.org/keywords/polyunsaturated-fatty-acids","display_name":"polyunsaturated fatty acids","score":0.8970000147819519},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9290000200271606},{"id":"https://openalex.org/keywords/psychosis-prevention","display_name":"psychosis prevention","score":0.7310000061988831},{"id":"https://openalex.org/keywords/high-risk-individuals","display_name":"high-risk individuals","score":0.5370000004768372},{"id":"https://openalex.org/keywords/omega-3-supplementation","display_name":"omega-3 supplementation","score":0.5699999928474426},{"id":"https://openalex.org/keywords/meta-analysis","display_name":"meta-analysis","score":0.8059999942779541}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5566196441650391},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46021902561187744},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4331350326538086},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.07095220685005188},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.03502160310745239}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:891726648","doi":null,"is_oa":true,"landing_page_url":"http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.psjd-5a24a6af-8ef5-4854-97a6-c256a03649e9/c/potencjalna-rola-wielonienasyconych-kwasow-tluszczowych-omega-3-w-terapii-schizofrenii-oraz-profilaktyce-wtornej-wsrod-osob-zagrozonych-rozwojem-psychozy-dane-z-randomizowanych-kontrolowanych-placebo-badan-klinicznych-ora.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2739126905","display_name":"Psychiatria i Psychologia Kliniczna","issn_l":"1644-6313","issn":["1644-6313","2451-0645"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310317365","host_organization_name":"Medical Communications Sp. z o.o.","host_organization_lineage":["https://openalex.org/P4310317365"],"host_organization_lineage_names":["Medical Communications Sp. z o.o."],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Psychiatria i Psychologia Kliniczna","raw_type":null}],"best_oa_location":{"id":"mag:891726648","doi":null,"is_oa":true,"landing_page_url":"http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.psjd-5a24a6af-8ef5-4854-97a6-c256a03649e9/c/potencjalna-rola-wielonienasyconych-kwasow-tluszczowych-omega-3-w-terapii-schizofrenii-oraz-profilaktyce-wtornej-wsrod-osob-zagrozonych-rozwojem-psychozy-dane-z-randomizowanych-kontrolowanych-placebo-badan-klinicznych-ora.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2739126905","display_name":"Psychiatria i Psychologia Kliniczna","issn_l":"1644-6313","issn":["1644-6313","2451-0645"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310317365","host_organization_name":"Medical Communications Sp. z o.o.","host_organization_lineage":["https://openalex.org/P4310317365"],"host_organization_lineage_names":["Medical Communications Sp. z o.o."],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Psychiatria i Psychologia Kliniczna","raw_type":null},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W83412252","https://openalex.org/W1841006886","https://openalex.org/W1926187054","https://openalex.org/W1931020215","https://openalex.org/W1941769213","https://openalex.org/W1975464025","https://openalex.org/W1976484727","https://openalex.org/W1979122474","https://openalex.org/W1993206740","https://openalex.org/W1996015317","https://openalex.org/W2000439674","https://openalex.org/W2026855969","https://openalex.org/W2029173677","https://openalex.org/W2033208205","https://openalex.org/W2040401967","https://openalex.org/W2046734045","https://openalex.org/W2053218327","https://openalex.org/W2053709052","https://openalex.org/W2058834304","https://openalex.org/W2064510510","https://openalex.org/W2086011692","https://openalex.org/W2088242403","https://openalex.org/W2093085396","https://openalex.org/W2102023134","https://openalex.org/W2103513447","https://openalex.org/W2104309828","https://openalex.org/W2107405545","https://openalex.org/W2114628261","https://openalex.org/W2117270933","https://openalex.org/W2129465602","https://openalex.org/W2130279922","https://openalex.org/W2131417790","https://openalex.org/W2145098771","https://openalex.org/W3112297277"],"related_works":["https://openalex.org/W1040164374","https://openalex.org/W2535186587","https://openalex.org/W7097430204","https://openalex.org/W7208024658","https://openalex.org/W7029667535","https://openalex.org/W2437894112","https://openalex.org/W2593323100","https://openalex.org/W975684486","https://openalex.org/W2948061096","https://openalex.org/W2159339551"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2016-06-24T00:00:00"}